Depixus
Magnetic force spectroscopy instruments for researchers studying biomolecular interactions and drug discovery
Highlights
- New on EvolcAdded 2026-10-29
About Depixus
Depixus develops and commercializes MAGNA One, a magnetic force spectroscopy instrument that measures individual biomolecular interactions in real time and in parallel. Its technology generates kinetic and thermodynamic data on molecular interactions.
Researchers use MAGNA One in drug discovery and applied and biophysics research, including studies of proteins, RNA, DNA, antibodies and small molecules. The company is headquartered in Courbevoie, France, with offices and laboratories in the Paris area.
Product: MAGNA One magnetic force spectroscopy instrument, with kits, reusable cartridges and software for analyzing biomolecular interactions.
Jobs at Depixus
Leadership
- Gordon Hamilton · Founder & Chief Executive OfficerSource: company website
- Thibault Vieille · Vice President of EngineeringSource: company website
More biotech & pharma companies
Diogenx
Preclinical biotech developing regenerative protein therapies for type 1 diabetes, aimed at restoring insulin-producing beta cellsNew on EvolcDiscngine
Scientific software and custom IT services for life science research and early drug discovery teamsNew on EvolcDNA Script
Benchtop enzymatic DNA synthesis system for labs that need ready-to-use oligos in-house, overnightNew on EvolcRemote-friendlyDomes Pharma
Veterinary pharmaceutical group making animal health products for vets, pharmacies and pet owners in France and abroadNew on EvolcEdelris
Drug discovery CRO offering compound libraries, screening and medicinal chemistry to pharma and biotech teamsNew on EvolcEligo Bioscience
In vivo microbiome gene-editing technologies for developing targeted therapies for human diseaseNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Cloudflare
- Google Analytics 4
- Google reCAPTCHA
- LiteSpeed
- PHP
- WordPress
- jQuery